Results 221 to 230 of about 3,006,184 (303)

Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

Genes & cancer, 2010
Shashidhar S. Jatiani, S. Baker, L. Silverman, E. Reddy   +3 more
semanticscholar   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Myocardial infarction as a thrombotic complication of myeloproliferative disorders. [PDF]

Anatol J Cardiol, 2016
Petrou E, Karali V.
europepmc   +1 more source

Myeloproliferative disorder of rats induced by myeloproliferative sarcoma virus.

, 1987
Shinji Itoyama, Yoshitake Hayashi
openalex   +2 more sources

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. [PDF]

Biol Blood Marrow Transplant, 2019
Gupta V, Kosiorek HE, Mead A, Klisovic RB, Galvin JP, Berenzon D, Yacoub A, Viswabandya A, Mesa RA, Goldberg J, Price L, Salama ME, Weinberg RS, Rampal R, Farnoud N, Dueck AC, Mascarenhas JO, Hoffman R.   +17 more
europepmc   +1 more source

Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho–myeloproliferative disorders and disseminated intravascular coagulation [PDF]

, 2015
Simonetta Astigiano, Monica Morini, Patrizia Damonte, Giulio Fraternali Orcioni, Michela Cassanello, Andrea Puglisi, Douglas M. Noonan, Vincenzo Bronte, Ottavia Barbieri   +8 more
openalex   +1 more source

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

Leukemia, 2009
M. Rohrbacher, U. Berger, A. Hochhaus, G. Metzgeroth, K. Adam, T. Lahaye, Susanne Saussele, M. Müller, J. Hasford, H. Heimpel, R. Hehlmann   +10 more
semanticscholar   +1 more source

Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome [PDF]

, 2008
Anita Chopra, Rajive Kumar, Madhulika Kabra, Mona Anand   +3 more
openalex   +1 more source

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. [PDF]

Blood Adv, 2018
Sengsayadeth S, Gatwood KS, Boumendil A, Labopin M, Finke J, Ganser A, Stelljes M, Ehninger G, Beelen D, Niederwieser D, Blaise D, Dreger P, Mufti G, Chevallier P, Mailhol A, Gilleece MH, Gorin N, Esteve J, Ciceri F, Baron F, Schmid C, Giebel S, Mohty M, Savani BN, Nagler A.   +24 more
europepmc   +1 more source

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

, 2007
Judith E. Karp, Francis J. Giles, Ivana Gojo, Lawrence E. Morris, Jacqueline M. Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer A. Low   +8 more
openalex   +1 more source